Drug testing is the technology of addiction medicine, says ASAM Member Dr. Robert DuPont, FASAM, in an enlightening video interview about ASAM's recently released Drug Testing White Paper.
ASAM takes a step toward the future with the launch of a National Demonstration Project for The ASAM Criteria Software.
The nation only treats the symptoms of this metastatic cultural cancer, not the disease. What are we going to do about it?
ASAM Member Dr. John Femino, MD, FASAM, offers help in creating legislation to ban synthetic cannabinoids.
With journal Co-Editors, the Editor-in-Chief ensures content is clinically accurate, timely and targeted to the readership and editorial mission. Applications for this position must be received to by 5:00 PM Eastern on Monday, May 26.
© 2014 American Society of Addiction Medicine. All rights reserved.
4601 N. Park Avenue, Upper Arcade #101, Chevy Chase, MD 20815
Phone: 301-656-3920 |
Fax: 301-656-3815 |
Association Web Design by Matrix Group International, Inc.
Connect With Us